Table 1 Comparison of the Rosenwax and Murtagh methods for estimating the need for palliative care
Rosenwax Method | n | Murtagh Method | n | Difference | ||
|---|---|---|---|---|---|---|
Neoplasm | C00–D48 | 230.840 (25.82 %) | Malignant neoplasm | C00–C97 | 223.842 (25.04 %) | 6.998 |
Cancer (breast) | C50 | 18.009 (2.01 %) | ||||
Cancer (colorectal) | C18–C21 | 25.693 (2.87 %) | ||||
Cancer (lung) | C30–C39 | 46.896 (5.25 %) | ||||
Cancer (prostate) | C61 | 13.408 (1.5 %) | ||||
Cancer (other) | 119.836 (13.41 %) | |||||
Heart failure | I110,I119, I500,I501,I509, I130,I132 | 74.704 (8.36 %) | Heart disease (chronic) | I00–I52 | 274.821 (30.75 %) | 258.673 |
Cerebrovascular disease (stroke) | I60–I69 | 58.556 (6.55 %) | ||||
Renal failure | N10, N11, N18, N120, N131, N132 | 8.588 (0.96 %) | Renal disease (chronic renal failure) | N17, N18, N28, I12, I13 | 18.817 (2.11 %) | 10.229 |
Liver failure | K704, K711, K721, K729 | 493 (0.06 %) | Liver disease | K70–K77 | 15.255 (1.71 %) | 14.762 |
Chronic obstructive pulmonary disease | J40, J410, J411, J418, J42, 430–J449 | 31.570 (3.53 %) | Respiratory disease | J06–J18, J20–J22, J40–J47 & J96 | 55.557 (6.22 %) | 23.987 |
Neurodegenerative disease | G10, G122, G20 | 10.841 (1.21 %) | Neurodegenerative disease | G10, G20, G35, G122, G903, G231 | 12.349 (1.38 %) | 1.508 |
Huntington’s disease | G10 | 332 (0.04 %) | ||||
Motor neuron disease | G122 | 1.878 (0.21 %) | ||||
Parkinson’s disease | G20 | 8.631 (0.97 %) | ||||
Alzheimer’s disease | G300, G301, G308, G309 | 6.252 (0.70 %) | Dementia, Alzheimer’s, senility | F01, F03, G30, R54 | 37.683 (4.22 %) | 31.431 |
HIV/AIDS | B20–B24 | 401 (0.04 %) | HIV/AIDS | B20–B24 | 401 (0.045 %) | 0 |
Total deaths from these conditions | 363.689 40.7 % of all deaths (n = 893.825) | Total deaths from these conditions | 697.281 78.0 % of all deaths (n = 893.825) | |||